GeneDx Holdings Corp. (WGS) › Shareholders' EquityGeneDx Holdings Corp. (WGS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$55.97M2019: -$88.71M2020: -$330.05M2021: $388.10M2022: $253.71M2023: $228.02M2024: $245.25M2025: $308.18M$308.18M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$308.18M+25.7%2024$245.25M+7.6%2023$228.02M-10.1%2022$253.71M-34.6%2021$388.10M+217.6%2020-$330.05M-272.1%2019-$88.71M-58.5%2018-$55.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share